Baidu
map

BMJ:Meta分析显示室内日光浴与基底和鳞状细胞癌发生相关

2012-10-16 MedSci BMJ

       最新Meta分析显示,室内日光浴与基底和鳞状细胞癌的发生强烈相关。暴露于室内日光浴(使用日光浴床、日光浴灯、日光浴亭或日光浴室)的个体发生基底细胞癌和鳞状细胞癌的风险分别比无此暴露者增高29%和67%。   这项Meta分析纳入1985~2012年在6个国家开展的12项研究,其中病例对照研究10项,巢式病例对照研究1项,队列研究1项,合计人数为80,

  

    最新Meta分析显示,室内日光浴与基底和鳞状细胞癌的发生强烈相关。暴露于室内日光浴(使用日光浴床、日光浴灯、日光浴亭或日光浴室)的个体发生基底细胞癌和鳞状细胞癌的风险分别比无此暴露者增高29%和67%。

  这项Meta分析纳入1985~2012年在6个国家开展的12项研究,其中病例对照研究10项,巢式病例对照研究1项,队列研究1项,合计人数为80,661例,其中9,328例为非黑色素瘤皮肤癌。

  研究者发现,基底细胞癌和鳞状细胞癌的总体相对风险分别为1.29和1.67。敏感性分析也观察到相似结果。

  为了确定是否存在量效反应关系,研究者对评价经常或多次暴露于室内日光浴的效应的研究进行了额外分析。结果显示,这种大剂量暴露与基底细胞癌风险增加相关,但增幅无统计学意义。此外,研究者对评价25岁以下者的暴露风险的研究进行额外分析发现,暴露于室内日光浴的25岁以下者发生基底细胞癌和鳞状细胞癌的相对风险分别为1.40和2.02。

  将总体风险估计值应用于美国的室内日光浴暴露率后计算发现,基底细胞癌和鳞状细胞癌的人群归因风险分数分别为3.7%和8.2%,相当于98,408例基底细胞瘤和72,244例鳞状细胞癌,因此每年归因于室内日光浴的非黑色素瘤皮肤癌例数为170,652例。

  该研究获得了国立研究资源中心和国立关节炎、肌肉骨骼和皮肤病研究所的支持。一名研究者与基因泰克公司存在联系。

  专家评论:

  澳大利亚昆士兰医学研究所的高级研究员Catherine M. Olsen女士和癌症与人群研究部主任Adèle C. Green女士表示,此前已知室内日光浴可导致黑色素瘤,世界卫生组织因此将其与石棉暴露和吸烟一并归为1类致癌物。上述研究得出的确凿证据表明,室内日光浴还与基底细胞癌和鳞状细胞癌呈强烈正相关。同时该研究还发现一些量效关系的证据,并证实暴露于室内日光浴的年龄越小,风险越大。基底细胞癌和鳞状细胞癌的治疗对患者和医疗系统产生的经济负担非常巨大,因此应尽量减少此类室内日光浴暴露(BMJ 2012;345:e6101 [doi:10.1136/bmj.e6101])。

链接:

Wehner MR, Shive ML, Chren MM, Han J, Qureshi AA, Linos E.Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis.BMJ. 2012 Oct 2;345:e5909. doi: 10.1136/bmj.e5909.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1887332, encodeId=44cf188e3326c, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Dec 04 22:25:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758756, encodeId=8d091e5875664, content=<a href='/topic/show?id=8dfe5919e49' target=_blank style='color:#2F92EE;'>#日光浴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59197, encryptionId=8dfe5919e49, topicName=日光浴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64c537366410, createdName=ms3323097325231039, createdTime=Sun Jun 23 08:25:00 CST 2013, time=2013-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895645, encodeId=ec571895645cf, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Jan 17 18:25:00 CST 2013, time=2013-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847477, encodeId=e04f184e4778d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jul 03 20:25:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978339, encodeId=cf2e19e833949, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Jul 25 07:25:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2012-12-04 guojianrong
  2. [GetPortalCommentsPageByObjectIdResponse(id=1887332, encodeId=44cf188e3326c, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Dec 04 22:25:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758756, encodeId=8d091e5875664, content=<a href='/topic/show?id=8dfe5919e49' target=_blank style='color:#2F92EE;'>#日光浴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59197, encryptionId=8dfe5919e49, topicName=日光浴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64c537366410, createdName=ms3323097325231039, createdTime=Sun Jun 23 08:25:00 CST 2013, time=2013-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895645, encodeId=ec571895645cf, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Jan 17 18:25:00 CST 2013, time=2013-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847477, encodeId=e04f184e4778d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jul 03 20:25:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978339, encodeId=cf2e19e833949, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Jul 25 07:25:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1887332, encodeId=44cf188e3326c, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Dec 04 22:25:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758756, encodeId=8d091e5875664, content=<a href='/topic/show?id=8dfe5919e49' target=_blank style='color:#2F92EE;'>#日光浴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59197, encryptionId=8dfe5919e49, topicName=日光浴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64c537366410, createdName=ms3323097325231039, createdTime=Sun Jun 23 08:25:00 CST 2013, time=2013-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895645, encodeId=ec571895645cf, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Jan 17 18:25:00 CST 2013, time=2013-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847477, encodeId=e04f184e4778d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jul 03 20:25:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978339, encodeId=cf2e19e833949, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Jul 25 07:25:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2013-01-17 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=1887332, encodeId=44cf188e3326c, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Dec 04 22:25:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758756, encodeId=8d091e5875664, content=<a href='/topic/show?id=8dfe5919e49' target=_blank style='color:#2F92EE;'>#日光浴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59197, encryptionId=8dfe5919e49, topicName=日光浴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64c537366410, createdName=ms3323097325231039, createdTime=Sun Jun 23 08:25:00 CST 2013, time=2013-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895645, encodeId=ec571895645cf, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Jan 17 18:25:00 CST 2013, time=2013-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847477, encodeId=e04f184e4778d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jul 03 20:25:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978339, encodeId=cf2e19e833949, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Jul 25 07:25:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2013-07-03 gaoxiaoe
  5. [GetPortalCommentsPageByObjectIdResponse(id=1887332, encodeId=44cf188e3326c, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Dec 04 22:25:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758756, encodeId=8d091e5875664, content=<a href='/topic/show?id=8dfe5919e49' target=_blank style='color:#2F92EE;'>#日光浴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59197, encryptionId=8dfe5919e49, topicName=日光浴)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64c537366410, createdName=ms3323097325231039, createdTime=Sun Jun 23 08:25:00 CST 2013, time=2013-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895645, encodeId=ec571895645cf, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Jan 17 18:25:00 CST 2013, time=2013-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847477, encodeId=e04f184e4778d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jul 03 20:25:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978339, encodeId=cf2e19e833949, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Thu Jul 25 07:25:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]

相关资讯

卷曲形与直形腹膜透析管

文献标题:Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and meta-analysis. 文献出处:Am J Kidney Dis. 2011 Dec;58(6):946-55. 期刊影响因子:5.242     腹膜透析管的设计存在许多不同方

正确认识和提高荟萃分析(meta分析)质量

 荟萃(Meta)分析是一种统计方法,被用于比较和综合针对同一科学问题所取得的研究结果,得出更可靠的结论。当研究结果存在矛盾而目前又没有能力实施大规模临床研究时,研究者需要采用Meta分析,为决策提供依据,对于已有公认的结论,一般无须进行Meta分析。   Meta分析局限性   理想Meta分析是指纳入所有高质量、同质的研究,无发表偏倚,并采用正确统计方法。然而,由于纳入所有研究十分困难,并

怎样应用系统性综述?系统性综述与Meta分析区别

     系统性综述的英文名称有systematic review, overview和meta-analysis。我们用overview表示系统性综述的统称, 用meta-analysis代表定量系统性综述。系统性综述的实施步骤包括: 拟定主题, 检索、 选择和评价有关素材(原始文献), 综合有关数据或资料, 及得出结论。系统性综述可以用于治疗、 病因、 诊断和预后

饮酒与喉癌:整体和饮用量-风险关系的系统性回顾和荟萃分析

    饮酒是喉癌的一个已知危险因素。然而,目前关于轻度饮酒与喉癌风险的资料很少。为了阐明这一问题,我们采用两种方法进行荟萃分析:(1)通过随机效应模型重建饮酒类别,使用Hamling法根据预先设定的饮酒量计算风险估计值;(2)随机效应多元回归模型。在PubMed数据库中检索所有关于饮酒与喉癌风险的相关英文病例对照研究或队列研究。40项报告了至少3个饮酒水平

Baidu
map
Baidu
map
Baidu
map